Burkholderia cenocepacia

Source: Wikipedia, the free encyclopedia.

Burkholderia cenocepacia
Electron micrograph of Burkholderia cepacia
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Pseudomonadota
Class: Betaproteobacteria
Order: Burkholderiales
Family: Burkholderiaceae
Genus: Burkholderia
Species:
B. cenocepacia
Binomial name
Burkholderia cenocepacia
Vandamme et al. 2003

Burkholderia cenocepacia is a

bacterium that is commonly found in soil and water environments and may also be associated with plants and animals, particularly as a human pathogen.[1] It is one of over 20 species in the Burkholderia cepacia complex (Bcc) and is notable due to its virulence factors and inherent antibiotic resistance that render it a prominent opportunistic pathogen responsible for life-threatening, nosocomial infections in immunocompromised patients, such as those with cystic fibrosis or chronic granulomatous disease.[2] The quorum sensing systems CepIR and CciIR regulate the formation of biofilms and the expression of virulence factors such as siderophores and proteases.[3] Burkholderia cenocepacia may also cause disease in plants, such as in onions[4][5] and bananas.[6] Additionally, some strains serve as plant growth-promoting rhizobacteria.[7]

Taxonomy

Within the Burkholderia genus, the Burkholderia cepacia complex contains over 20 related species that cause

antibiotic resistance.[8] Burkholderia cepacia was originally defined as a single species, but it is now one of several species in the Bcc.[9] Although closely related, the species within the Bcc have differing severity of pathogenicity, and B. cenocepacia is one of the most intensively studied due to its higher pathogenicity and antibiotic resistance compared to other species in the complex.[8] Exchange of genetic material between species of the Bcc has resulted in a reticulated phylogeny that presents an obstacle to diagnostic classification at the species-level.[8] Because of this phenotypic overlap between species, previous nomenclature of Bcc species involved genomovar terms, with Burkholderia cenocepacia categorized as genomovar III of the Bcc.[6][10] Within the categorization as genomovar III, there are 4 phylogenetic lineage groups: IIIA, IIIB, IIIC, and IIID.[11] No IIIC isolates have been found in studies on the natural environment, whereas all IIID isolates studied have been in clinical isolates of B. cenocepacia.[12]

Microbiology

The strong environmental protection response of B. cenocepacia is attributed to the biofilm formed by groups of the organism.

neutrophils from human immune resistance systems, undermining the neutrophil defense action by inhibiting neutrophil chemotaxis and scavenging reactive oxygen species, which are bactericidal products produced by neutrophils to destroy bacteria.[15]

Genome

B. cenocepacia's genome consists of three circular chromosomes and one plasmid. Chromosome 1 contains 3.87 Mb, chromosome 2 contains 3.22 Mb, and chromosome 3 contains 0.88 Mb. The plasmid is approximately 0.09 Mb.[16] Chromosome 3 has also been characterized as a large plasmid, or megaplasmid (pC3); unlike chromosomes 2 and 3, it does not contain essential housekeeping genes, instead coding for accessory functions such as virulence and resistance to stress.[17][18] In addition to the multireplicon structure, the genome contains several insertion sequences and can rapidly mutate during infections, which contribute to B. cenocepacia's unique adaptability and ability to acquire diverse catabolic functions.[19][20]

Environments

Burkholderia cenocepacia has been found to thrive in primarily microaerophilic conditions, which consist of little to no oxygen.[21] Experimental studies conducted on the growth of B. cenocepacia in environments akin to the human lungs demonstrated the pathogen's increased success in microaerophilic environments over aerophilic settings.[21] In environments with little available iron such as the lungs of a cystic fibrosis patient, Burkholderia cenocepacia secretes siderophores, molecules that bind to iron and transport them to the bacteria.[22] Out of the four types of siderophores produced by the Bcc, B. cenocepacia produces three: ornibactin, pyochelin, and salicylic acid (SA). Ornibactin is the most important iron uptake system and can sustain the bacteria in an iron-deficient environment even without the production of functioning pyochelin or SA.[23]

B. cenocepacia has been demonstrated to colonize an array of ecological niches with diverse lifestyles. The ability to utilize a wide range of carbon sources accompanies the ability of Bcc species to be efficient with plant-growth promotion, bioremediation, and biocontrol.[12][24] High potential of Bcc species, including B. cenocepacia, as a biocontrol of plant-growth promoting agents has been demonstrated; however, the mechanisms that support this are not known.[12] In a bioremediation context, various Bcc strains are suggested to hold high potential to remediate environments contaminated with toxic compounds, including halogenated compounds.[12]

In addition, B. cenocepacia has been found to exist in the rhizosphere, plants, soil, water, and animals.

phytopathogenic properties in causing fingertip rot in bananas.[6]

Quorum sensing

One kind of cell-to-cell communication employed by B. cenocepacia is quorum sensing, which is the detection of fluctuations in cell density and usage of this information to regulate functions such as the formation of biofilms. Like other Gram-negative bacteria, B. cenocepacia produces acyl-homoserine lactones (AHLs), signaling molecules that in members of the Burkholderia cepacia complex specifically are encoded by two systems–the CepIR system, which is highly conserved in the Bcc, and the CciIR system.[26] The two AHL-mediated QS systems, CepIR and CciIR, regulate each other; the CepR protein is required for the transcription of the cciIR operon, while the CciR protein represses transcription of cepI. The CciIR system can also negatively regulate the CepIR system through the production of C6-HSL, a type of AHL produced primarily by CciI proteins that inhibits the activity of CepR proteins.[26][27] The bacterium also uses cis-2-dodecenoic acid signals, which are known as Burkholderia diffusible signal factors (BDSF) because they were first identified in Burkholderia cenocepacia.[28]

Motility

Burkholderia cenocepacia has the ability to swim and swarm inside the body. It has a polar flagella and produces a surfactant. These characteristics are necessary for the species to have motility in an agar medium. The surfactant produced by Burkholderia cenocepacia allows other pathogenic bacteria in the lungs to have motility. This means that the presence of Burkholderia cenocepacia is necessary for swarms of bacteria to coexist and cooperate in the lungs.[29]

Pathogenicity

Burkholderia cenocepacia is an

opportunistic pathogen that commonly infects immunocompromised patients, especially those with cystic fibrosis, and is often lethal.[30] In cystic fibrosis, it can cause "cepacia syndrome," which is characterized by a rapidly progressive fever, uncontrolled bronchopneumonia, weight loss, and in some cases, death. A review of B. cenocepacia in respiratory infections of cystic fibrosis patients stated that "one of the most threatening pathogens in [cystic fibrosis] is Burkholderia cenocepacia, a member of a bacterial group collectively referred to as the Burkholderia cepacia complex."[31] Twenty-four small RNAs were identified using RNA-binding properties of the Hfq protein during the exponential growth phases.[32] sRNAs identified in Burkholderia cenocepacia KC-0 were upregulated under iron depletion and oxidative stress.[33]
Burkholderia cenocepacia encodes two RNA chaperone proteins that assist sRNAs in binding to mRNA, Hfq and Hfq2. Both are required for maximum virulence and resistance against stressors such as acidic pH, high temperatures, osmotic stress, and oxidative stress.
mitochondria – for which a team at the Broad Institute developed a new kind of CRISPR-free base editor, called DdCBE, using the toxin.[37][38][39]

See also: Burkholderia thailandensis sRNA

Antibiotic resistance

The structural factors that contribute to the antibiotic resistance of B. cenocepacia include: an impermeable outer membrane, an

efflux pump mechanism, and the production of a beta-lactamase.[40] This microbe challenges infection prevention as it is resistant to some disinfectants and antiseptics. It can survive on surfaces, including human skin and mucosal surfaces for an extended period of time.[41]

Virulence

Virulence in Burkholderia cenocepacia is widely attributed to biofilm formation, siderophore production, and QS signaling - each of which affect how the species adapts in various environmental conditions.[22] B. cenocepacia's ability to adapt to host environments contributes to chronic opportunistic infections and bacterial persistence.[19] Several strains are noted as "epidemic strains" due to increased transmission capability and patient-to-patient transmission.[12] The ET12 strain was found to have a "cable pilus," which enables greater adhesion of bacteria to epithelial cells.[12]

In human airway epithelial cells, the invasion pathway utilized by the BC-7 strain of B. cenocepacia is largely the result of the strain's biofilm formation.[42] In general, both environmental and clinical strains of B. cenocepacia are able to form biofilms; however, the ability to do so is greater in clinical strains.[43] The H111 strain of Burkholderia cenocepacia forms biofilms on pea roots, for example.[44] Quorum signaling (QS) affects the ability of B. cenocepacia to develop biofilms, in addition to the motility abilities.[45] In addition, quorum signaling controls a variety of cellular processes, such as extracellular proteases, polygalacturonase, and the production of siderophores.[45]

Cystic fibrosis

Burkholderia cenocepacia is one of over twenty bacteria in the Burkholderia cepacia complex (Bcc), and among these species, it is a dominant bacteria associated with

FEV1 (forced expiration) at the greatest rate, leading to worse prognoses for cystic fibrosis patients.[46] The Bcc complex consists of genomovars, which are species characterized to be phylogenetically close, though distinct from each other.[47] In cystic fibrosis infections, it is common for only one of the known nine genomovars to induce an infection.[47] Overall, in patients with cystic fibrosis, the genomovar status of the Bcc has a significant influence on the success of clinical interventions, as well as the temporal progression of the condition.[48]

Applications

Biotechnology

Given the opportunistic nature of the Bcc complex and B. cenocepacia, the severity of respiratory infections is considered to be a significant conflict for applications in biotechnology.[12]

Agriculture

To increase soil health,

plant-growth promoting rhizobacteria (PGPR) are used in the agricultural industry to create bio-organic fertilizers.[49] A current challenge is identifying which bacterial species are optimal at stimulating plant growth in bio-organic fertilizers. Creating bio-organic fertilizers has been increasingly successful with the use of plant-growth promoting rhizobacteria mixed with organic substrates.[49] B. cenocepacia has various PGPR traits like phosphate solubilization that make it well-suited to promote growth. With the addition of solid-state fermentation technology, creating bio-organic fertilizers was highly successful by incorporating B. cenocepacia with high protein content agricultural wastes.[49]

References

  1. PMID 22919581
    .
  2. PMID 34372537
    .
  3. PMID 27580679
    .
  4. PMID 34351603
    .
  5. PMID 18344334
    .
  6. ^
    PMID 18944375
    .
  7. S2CID 209445961
    .
  8. ^
    PMID 32878952
    .
  9. PMID 32295766
    .
  10. S2CID 19117513
    .
  11. PMID 12648723
    .
  12. ^
    PMID 20880095
    .
  13. PMID 27179816
    . B. cenocepacia can spread from person to person and exhibits intrinsic broad-spectrum antibiotic resistance
  14. PMID 15463903
    .
  15. PMID 16316987
    . We showed that EPS from a clinical B. cenocepacia isolate interfered with the function of human neutrophils in vitro; it inhibited chemotaxis and production of reactive oxygen species (ROS), both essential components of innate neutrophil-mediated host defenses
  16. PMID 22919581
    .
  17. PMID 24334662
    .
  18. S2CID 12668288
    .
  19. ^
    PMID 20643851
    .
  20. S2CID 46192579
    .
  21. ^
    PMID 21536796
    .
  22. ^
    PMID 20880411
    .
  23. PMID 15102796
    .
  24. S2CID 23275498
    .
  25. PMID 17233735
    .
  26. ^
    PMID 23799665
    .
  27. PMID 19761612
    .
  28. PMID 34985987
    .
  29. PMID 35862793
    .
  30. PMID 27871013
    . It is recognized as an opportunistic human pathogen causing lung infections in immunocompromised individuals, especially in cystic fibrosis patients, with significant mortality and morbidity
  31. PMID 20880411
    .
  32. PMID 23142676
    .
  33. PMID 29099689
    .
  34. PMID 21278292
    .
  35. PMID 28106859
    .
  36. PMID 33448264
    .
  37. ^ "The powerhouses inside cells have been gene-edited for the first time". New Scientist. 8 July 2020. Retrieved 12 July 2020.
  38. ^ McRae M (10 July 2020). "For The First Time, Scientists Find a Way to Make Targeted Edits to Mitochondrial DNA". Science Alert.
  39. PMID 32641830
    .
  40. S2CID 209445961
    .
  41. PMID 34579569
    .
  42. PMID 12117967
    .
  43. S2CID 35624527
    .
  44. OCLC 153550538
    .
  45. ^
    PMID 16490397
    .
  46. ^
    PMID 15463892
    .
  47. ^
    ISBN 978-0-323-04048-8
    .
  48. PMID 15516469
    .
  49. ^
    S2CID 242072559
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Burkholderia_cenocepacia&oldid=1213906812"